Latest Breaking News On - Pharmaceutics international inc - Page 3 : vimarsana.com

Skye Bioscience Inc gets regulatory approval to begin first-in-human Phase 1 clinical study of SBI-100 Ophthalmic Emulsion as potential treatment for glaucoma

"After submitting our clinical trial protocol to HREC in March, we are pleased to receive their approval and look forward to assessing.

South australiaSkye biosciencePunit dhillonTu diepAustralian human research ethics committeeAustralian department of healthClinical researchPharmaceutics international incUs drug enforcement agencySafety review committeeClinical trial notificationAustralian therapeutic goodsAustralian departmentEnforcement agency

Skye Bioscience (SKYE) Granted Australian Ethics Committee Approval to Start First-in-Human Phase 1 Study of SBI-100

Skye Bioscience (SKYE) Granted Australian Ethics Committee Approval to Start First-in-Human Phase 1 Study of SBI-100
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South australiaPunit dhillonTu diepAustralian human research ethics committeeSkye bioscience incAustralian department of healthClinical researchPharmaceutics international incUs drug enforcement agencySafety review committeeWall streetChief development officerClinical trial notificationAustralian therapeutic goodsAustralian departmentEnforcement agency

Skye Bioscience Receives Australian Ethics Committee Approval to Start First-in-Human Phase 1 Study of SBI-100 Ophthalmic Emulsion

Skye Bioscience Receives Australian Ethics Committee Approval to Start First-in-Human Phase 1 Study of SBI-100 Ophthalmic Emulsion
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesSouth australiaSkye biosciencePunit dhillonTu diepAustralian human research ethics committeeSkye bioscience incAustralian department of healthPharmaceutics international incUs drug enforcement agencyExchange commissionCalifornia newsfile corpClinical researchSafety review committeeWall street

Special Note Regarding Forward-Looking Statements Certain statements in this Report contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of. | May 13, 2022

New yorkUnited statesUtah state universityNew jerseyNew brunswickArgentine republicPawel kalinskiRintatolimod ampligenRoswell parkAlimentosy tecnologiaRobertp edwardsCasper van eijckHemispherx biopharma europeMonserrato cagliariContract research organizationUs centers for disease

Veteran Sales And Business Leader Christian Ahlmark Joins Pharmaceutics International Inc (Pii) As Vice President Of Sales And Business Development

In his new role, Christian will be responsible for leading his team in supporting Pii’s broad CDMO capabilities in oral drug and parenteral.

United statesHunt valleyJohn fowlerKemwell biopharmaCorden pharma internationalLancaster labs incBusiness development at pharmaceutics international incPharmaceutics international incAnalytical incCatalent pharma servicesMagellan laboratories incCorerx incBusiness developmentChristian ahlmarkVice presidentPharmaceutics international